Anteris Technologies Global (NASDAQ:AVR – Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.09), FiscalAI reports. Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. The firm had revenue of $1.01 million for the quarter, compared to the consensus estimate of $1.50 million.
Anteris Technologies Global Stock Performance
AVR traded up $0.21 during trading hours on Tuesday, reaching $9.17. The company’s stock had a trading volume of 1,096,833 shares, compared to its average volume of 1,175,484. The firm has a market cap of $892.61 million, a PE ratio of -4.11 and a beta of 1.79. Anteris Technologies Global has a 52 week low of $3.17 and a 52 week high of $11.06. The company’s 50-day moving average is $9.15 and its 200-day moving average is $7.31.
Insiders Place Their Bets
In other Anteris Technologies Global news, major shareholder L1 Capital Pty Ltd sold 558,633 shares of the business’s stock in a transaction dated Thursday, July 30th. The shares were sold at an average price of $8.20, for a total value of $4,580,790.60. Following the completion of the sale, the insider owned 6,633,314 shares of the company’s stock, valued at $54,393,174.80. The trade was a 7.77% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In the last quarter, insiders sold 2,373,000 shares of company stock worth $19,387,842. 4.50% of the stock is owned by company insiders.
Institutional Trading of Anteris Technologies Global
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on AVR shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anteris Technologies Global in a report on Friday, May 29th. Barclays upped their price objective on Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a report on Friday, May 15th. Finally, Wall Street Zen raised Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Four investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $16.00.
Read Our Latest Stock Analysis on AVR
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
See Also
- Five stocks we like better than Anteris Technologies Global
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
